Correlation Between GlucoTrack and BioLife Sciences
Can any of the company-specific risk be diversified away by investing in both GlucoTrack and BioLife Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and BioLife Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlucoTrack and BioLife Sciences, you can compare the effects of market volatilities on GlucoTrack and BioLife Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of BioLife Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and BioLife Sciences.
Diversification Opportunities for GlucoTrack and BioLife Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlucoTrack and BioLife is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and BioLife Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLife Sciences and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with BioLife Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLife Sciences has no effect on the direction of GlucoTrack i.e., GlucoTrack and BioLife Sciences go up and down completely randomly.
Pair Corralation between GlucoTrack and BioLife Sciences
If you would invest 0.01 in BioLife Sciences on August 25, 2024 and sell it today you would earn a total of 0.00 from holding BioLife Sciences or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.65% |
Values | Daily Returns |
GlucoTrack vs. BioLife Sciences
Performance |
Timeline |
GlucoTrack |
BioLife Sciences |
GlucoTrack and BioLife Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlucoTrack and BioLife Sciences
The main advantage of trading using opposite GlucoTrack and BioLife Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, BioLife Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Sciences will offset losses from the drop in BioLife Sciences' long position.GlucoTrack vs. Heartbeam | GlucoTrack vs. EUDA Health Holdings | GlucoTrack vs. Nutex Health | GlucoTrack vs. Healthcare Triangle |
BioLife Sciences vs. Innerscope Advertising Agency | BioLife Sciences vs. CeCors Inc | BioLife Sciences vs. GlucoTrack | BioLife Sciences vs. Sharps Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |